US2019127396A1PendingUtilityA1

Synthesis of boronate ester derivatives and uses thereof

Assignee: REMPEX PHARMACEUTICALS INCPriority: Nov 1, 2017Filed: Oct 31, 2018Published: May 2, 2019
Est. expiryNov 1, 2037(~11.3 yrs left)· nominal 20-yr term from priority
C07F 5/04C07C 67/31C07F 5/02C07C 69/675C12P 9/00C07F 5/025C12P 41/002B01J 23/462
61
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Disclosed herein are methods for the preparation of boronate derivatives in the synthesis of antimicrobial compounds and uses thereof. Disclosed herein includes method of making a compound of Formula (B) by reducing the ketone group of the keto-ester compound of Formula (A), and the reduction can be performed using a Ruthenium based catalyst system or using an alcohol dehydrogenase bioreduction system.

Claims

exact text as granted — not AI-modified
1 . A compound having the structure of Formula (I): 
       
         
           
           
               
               
           
         
         wherein X is a halogen and m is an integer between 2 and 6. 
       
     
     
         2 . The compound of  claim 1 , wherein X is Cl and m is 2. 
     
     
         3 . (canceled) 
     
     
         4 . A compound having the structure of Formula (II): 
       
         
           
           
               
               
           
         
         or a salt thereof, wherein: 
         X is a halogen, 
         m is an integer between 2 and 6, 
         each of R 1a  and R 1b  is independently selected from the group consisting of an optionally substituted C 1 -C 12  alkyl, optionally substituted C 3 -C 8  cycloalkyl, optionally substituted C 2 -C 12  alkenyl, optionally substituted C 2 -C 12  alkynyl, optionally substituted aryl, and optionally substituted heteroaryl, or 
         R 1a  and R 1b  together with intervening atoms optionally form a 5-7 membered boron ester ring, and 
         R 2  is selected from the group consisting of an optionally substituted C 1 -C 12  alkyl, optionally substituted C 3 -C 8  cycloalkyl, optionally substituted C 2 -C 12  alkenyl, optionally substituted C 2 -C 12  alkynyl, optionally substituted aryl, and optionally substituted heteroaryl. 
       
     
     
         5 . The compound of  claim 4 , wherein X is Cl and each of R 1a  and R 1b  are a butyl group. 
     
     
         6 - 8 . (canceled) 
     
     
         9 . A method of making a compound of Formula (B), comprising the steps of:
 reducing the ketone group of a compound of Formula (A):   
       
         
           
           
               
               
           
         
         to form a compound of Formula (B): 
       
       
         
           
           
               
               
           
         
         wherein: 
         X is a halogen, and 
         m is 2 to 6. 
       
     
     
         10 . The method of  claim 9 , wherein X is Cl and m is 2. 
     
     
         11 . (canceled) 
     
     
         12 . The method of  claim 9 , wherein the ketone group in the compound of Formula (A) is reduced using a Ruthenium based catalyst. 
     
     
         13 . The method of  claim 12 , wherein the Ruthenium based catalyst has the structure of Formula (III):
   R 3 Ru(X 1 ) 2    (III),
   wherein:   X 1  is a halogen, benzene, cymene, or an acetyl (OAc) group; and   R 3  is a ligand selected from the group consisting of (S)-BINA, (R)-BINAP, (R)—H 8 -BINAP, (R)-SegPhos, (R)-DM-SegPhos, (S)-SegPhos, (R)-tolyl-BINAP, (R)-xylyl-BINAP, (S)-tolyl-BINAP, (S)-BINAPHANE, (S)-PhanePhos, JosiPhos-2-1, (R)-SolPhos SL-A001-1, (S)-MeOBiPhep, (S)—P-Phos, and (S)-(+)-DTBM-SEGPHOS.   
     
     
         14 - 18 . (canceled) 
     
     
         19 . The method of  claim 9 , comprising reducing the ketone group in the compound of Formula (A) with an alcohol dehydrogenase system. 
     
     
         20 . The method of  claim 19 , wherein the alcohol dehydrogenase system comprises a reduced nicotinamide adenine dinucleotide (NADH), a reduced nicotinamide adenine dinucleotide phosphate (NADPH), and an alcohol. 
     
     
         21 - 26 . (canceled) 
     
     
         27 . A method of making a compound of Formula (C), comprising:
 reacting a boronate compound B(OR 4a )(OR 4b )(OR 4c ) with a compound of Formula (B-1):   
       
         
           
           
               
               
           
         
         to form the compound of Formula (C): 
       
       
         
           
           
               
               
           
         
         wherein: 
         X is a halogen; 
         m is an integer between 2 and 6; 
         R 2  is selected from the group consisting of an optionally substituted C 1 -C 12  alkyl, optionally substituted C 3 -C 8  cycloalkyl, optionally substituted C 2 -C 12  alkenyl, optionally substituted C 2 -C 12  alkynyl, optionally substituted aryl, and optionally substituted heteroaryl; 
         R 4a  and R 4b  are independently selected from the group consisting of an optionally substituted C 1 -C 12  alkyl, optionally substituted C 3 -C 8  cycloalkyl, optionally substituted C 2 -C 12  alkenyl, optionally substituted C 2 -C 12  alkynyl, optionally substituted aryl, and optionally substituted heteroaryl, or 
         R 4a  and R 4b  together with intervening atoms optionally form a 5-8 membered boron ester ring; and 
         R 4c  is selected from the group consisting of an optionally substituted C 1 -C 12  alkyl, optionally substituted C 3 -C 8  cycloalkyl, optionally substituted C 2 -C 12  alkenyl, optionally substituted C 2 -C 12  alkynyl, optionally substituted aryl, and optionally substituted heteroaryl. 
       
     
     
         28 . The method of  claim 27 , wherein X is Cl, m is 2, and R 2 , R 4a , and R 4b  are each independently a butyl group. 
     
     
         29 - 31 . (canceled) 
     
     
         32 . A method of making a compound of Formula (D), comprising:
 reacting magnesium with a compound of Formula (C):   
       
         
           
           
               
               
           
         
         to form a first reaction intermediate; and 
         hydrolyzing the first reaction intermediate to form the compound of Formula (D): 
       
       
         
           
           
               
               
           
         
         wherein: 
         X is a halogen, 
         m is an integer between 2 and 6, and 
         R 2  is selected from the group consisting of an optionally substituted C 1 -C 12  alkyl, optionally substituted C 3 -C 8  cycloalkyl, optionally substituted C 2 -C 12  alkenyl, optionally substituted C 2 -C 12  alkynyl, optionally substituted aryl, and optionally substituted heteroaryl, and 
         each of R 4a  and R 4b  are independently selected from the group consisting of an optionally substituted C 1 -C 12  alkyl, optionally substituted C 3 -C 8  cycloalkyl, optionally substituted C 2 -C 12  alkenyl, optionally substituted C 2 -C 12  alkynyl, optionally substituted aryl, and optionally substituted heteroaryl, or 
         R 4a  and R 4b  together with intervening atoms optionally form a 5-8 membered boron ester ring. 
       
     
     
         33 . The method of  claim 32 , wherein X is Cl, m is 2, and R 2 , R 4a , and R 4b  are independently a butyl group. 
     
     
         34 - 36 . (canceled) 
     
     
         37 . The method of  claim 32 , wherein the compound of Formula (D) is 
       
         
           
           
               
               
           
         
       
     
     
         38 - 40 . (canceled) 
     
     
         41 . A method of making a compound of Formula (E), comprising:
 reducing the ketone group of a keto-ester compound of Formula (A-1):   
       
         
           
           
               
               
           
         
         to form a compound of Formula (B-1): 
       
       
         
           
           
               
               
           
         
         reacting a boronate compound B(OR 4a )(OR 4b )(OR 4c ) with the compound of Formula (B) to form a compound of Formula (C): 
       
       
         
           
           
               
               
           
         
         reacting magnesium with the compound of Formula (C) to form a first reaction intermediate 
         hydrolyzing the first reaction intermediate to form a compound of Formula (D): 
       
       
         
           
           
               
               
           
         
       
       and
 reacting the compound of Formula (D) with a complexing agent of Formula (CL); 
 
       
         
           
           
               
               
           
         
         to form the compound of Formula (E): 
       
       
         
           
           
               
               
           
         
         wherein: 
         X is a halogen, 
         m is an integer between 2 and 6, 
         n is an integer between 0 and 6, 
         Y′ is O or N + R 9 R 10 ; 
         Y 2  is O or NR 11 ; 
         R 2  is selected from the group consisting of an optionally substituted C 1 -C 12  alkyl, optionally substituted C 3 -C 8  cycloalkyl, optionally substituted C 2 -C 12  alkenyl, optionally substituted C 2 -C 12  alkynyl, optionally substituted aryl, and optionally substituted heteroaryl, 
         each R 5  and R 6  are independently selected from the group consisting of H, optionally substituted phenyl, and optionally substituted C 1-4  alkyl, or R 5  and R 6  together with the atom to which they are attached, form ═O; 
         each R 7  and R 8  are independently selected from the group consisting of H, optionally substituted phenyl, and optionally substituted C 1-4  alkyl, or R 5  and R 7  together with the atom to which they are attached form an aryl or heteroaryl ring; or R 7  and R 8  together with the atom to which they are attached, form ═O; and 
         each R 9 , R 10 , and R 11  are independently selected from the group consisting of H, optionally substituted phenyl, and optionally substituted C 1-4  alkyl. 
       
     
     
         42 . The method of  claim 41 , wherein X is Cl, m is 2, and R 2  is a butyl group. 
     
     
         43 - 46 . (canceled) 
     
     
         47 . The method of  claim 41 , wherein the complexing agent of Formula (CL) is NH 2 (CH 2 ) 2 OH. 
     
     
         48 - 49 . (canceled) 
     
     
         50 . The method of  claim 41 , further comprising reacting the compound of Formula (E) with pinanediol to form a compound of Formula (F): 
       
         
           
           
               
               
           
         
         protecting the hydroxy group of the compound of Formula (F) with a PG group to form a compound of Formula (G): 
       
       
         
           
           
               
               
           
         
         reacting the compound of Formula (G) with n-butyllithium and dichloromethane to form a compound of Formula (H): 
       
       
         
           
           
               
               
           
         
         reacting the compound of Formula (H) with an LiN(SiR 12 ) 2  to form a compound of Formula (J): 
       
       
         
           
           
               
               
           
         
         reacting the compound of Formula (J) with R 13 —COCl to form a compound of Formula (K): 
       
       
         
           
           
               
               
           
         
       
       and
 removing the PG group on the compound of formula (K) to form a compound of formula (L): 
 
       
         
           
           
               
               
           
         
         wherein: 
         PG is a hydroxy protection group, 
         R 12  is optionally substituted phenyl or optionally substituted C 1-8  alkyl, and 
         R 13  is selected from optionally substituted C 1-8  alkyl, optionally substituted C 0-4  alkyl-C 6-10  aryl, optionally substituted C 0-4  alkyl-5-10 membered heteroaryl, optionally substituted C 0-4  alkyl-C 3-10  carbocyclyl, and C 0-4  alkyl-4-10 membered heterocyclyl. 
       
     
     
         51 - 53 . (canceled) 
     
     
         54 . The method of  claim 50 , wherein R 13  is

Join the waitlist — get patent alerts

Track US2019127396A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.